Plasma mid-regional pro-atrial natriuretic peptide and N-terminal pro-brain natriuretic peptide improve discrimination of lone atrial fibrillation
Chang, I.C.Y.; Chen, L.Y.; Chong, J.P.C.; Austin, E.; Quay, C.N.; Gong, L.; Mark Richards, A.; Ling, L.H.
International Journal of Cardiology 188: 10-12
2015
ISSN/ISBN: 1874-1754 PMID: 25880572 DOI: 10.1016/j.ijcard.2015.03.415
Accession: 058562936
Full Text Article emailed within 0-6 h: $19.90
Related References
Buckley, M.G.; Markandu, N.D.; Sagnella, G.A.; Macgregor, G.A. 1994: N-Terminal atrial natriuretic peptide and atrial natriuretic peptide in human plasma Investigation of plasma levels and molecular circulating form using radioimmunoassays for pro-atrial natriuretic peptide , pro-atrial natriuretic peptide and atrial natriuretic peptide Clinical Science 87(3): 311-317Buckley, M.G.; Markandu, N.D.; Sagnella, G.A.; Macgregor, G.A. 1994: N-terminal atrial natriuretic peptide and atrial natriuretic peptide in human plasma : investigation of plasma levels and molecular circulating form(s) using radioimmunoassays for pro-atrial natriuretic peptide (31-67), pro-atrial natriuretic peptide (1-30) and atrial natriuretic peptide (99-126) Clinical Science (1979) 87(3): 311-317
Buckley, M.G.; Markandu, N.D.; Sagnella, G.A.; MacGregor, G.A. 1994: N-terminal atrial natriuretic peptide and atrial natriuretic peptide in human plasma: investigation of plasma levels and molecular circulating form(s) using radioimmunoassays for pro-atrial natriuretic peptide (31-67), pro-atrial natriuretic peptide (1-30) and atrial natriuretic peptide (99-126) Clinical Science 87(3): 311-317
Eckstein, J.; Potocki, M.; Rubini Gimenez, M.; Morgenthaler, N.G.; Mueller, C.; Murray, K.; Breidthardt, T.; Ziller, R.; Mosimann, T.; Klima, T.; Hoeller, R.; Moehring, B.; Seoung Mann, S.O.U. 2012: Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea Heart (London 1996) 98(20): 1518-1522
Eckstein, J.; Potocki, M.; Murray, K.; Breidthardt, T.; Ziller, R.; Mosimann, T.; Klima, T.; Hoeller, R.; Moehring, B.; Sou, S.M.; Rubini Gimenez, M.; Morgenthaler, N.G.; Mueller, C. 2012: Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea Heart 98(20): 1518-1522
Ellinor, P.T.; Low, A.F.; Patton, K.K.; Shea, M.A.; Macrae, C.A. 2005: Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation Journal of the American College of Cardiology 45(1): 82-86
Chen, L. Y.; Chong, J. P.; Chang, I. C.; Austin, E.; Quay, C. N.; Richards, A. M.; Ling, L. H. 2013: Plasma mid-regional pro-atrial natriuretic peptide is associated with and improves prediction of lone atrial fibrillation European Heart Journal 34(Suppl 1): P4066-P4066
Liu, Y.; Xiao, Y.; Chen, X.; Zhang, F. 2014: Association between plasma brain natriuretic peptide/N-terminal pro-brain natriuretic peptide levels and atrial fibrillation: evidence from a meta-analysis Chinese Medical Journal 127(15): 2824-2828
Omland, T.; Aakvaag, A.; Bonarjee, V.V.; Caidahl, K.; Lie, R.T.; Nilsen, D.W.; Sundsfjord, J.A.; Dickstein, K. 1996: Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide Circulation 93(11): 1963-1969
Omland, T.; Aakvaag, A.; Bonarjee, V.V.S.; Caidahl, K.; Lie, R.T.; Nilsen, D.W.T.; Sundsfjord, J.A.; Dickstein, K. 1996: Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction : Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide Circulation 93(11): 1963-1969
Hülsmann, M.; Berger, R.; Mörtl, D.; Gore, O.; Meyer, B.; Pacher, R. 2005: Incidence of normal values of natriuretic peptides in patients with chronic heart failure and impact on survival: a direct comparison of N-terminal atrial natriuretic peptide, N-terminal brain natriuretic peptide and brain natriuretic peptide European Journal of Heart Failure 7(4): 552-556
Nishikimi, T.; Mori, Y.; Ishimura, K.; Tadokoro, K.; Yagi, H.; Yabe, A.; Horinaka, S.; Matsuoka, H. 2004: Association of plasma atrial natriuretic peptide, N-terminal proatrial natriuretic peptide, and brain natriuretic peptide levels with coronary artery stenosis in patients with normal left ventricular systolic function American Journal of Medicine 116(8): 517-523
Daggubati, S.; Parks, J.R.; Overton, R.M.; Cintron, G.; Schocken, D.D.; Vesely, D.L. 1997: Comparison of atrial natriuretic peptide, brain natriuretic peptide, C-natriuretic peptide, adrenomedullin, N-terminal proatrial and probrain natriuretic peptides as indicators of early congestive heart failure Journal of Investigative Medicine 45(3): 211A
Yamada, T.; Murakami, Y.; Okada, T.; Okamoto, M.; Shimizu, T.; Toyama, J.; Yoshida, Y.; Tsuboi, N.; Ito, T.; Muto, M.; Kondo, T.; Inden, Y.; Hirai, M.; Murohara, T. 2006: Plasma atrial natriuretic Peptide and brain natriuretic Peptide levels after radiofrequency catheter ablation of atrial fibrillation American Journal of Cardiology 97(12): 1741-1744
Hasegawa, Y.; Okada, S.; Sanada, A.; Tomii, A.; Sugiura, H.; Higuchi, K.; Chinushi, M.; Inomata, T. 2023: The Atrial Natriuretic Peptide-to-brain Natriuretic Peptide Ratio Predicts Left Atrial Reverse Remodeling after Rhythm Control Therapy in Patients with Persistent Atrial Fibrillation Internal Medicine 2023
Palà, E.; Pagola, J.; Juega, J.; Francisco-Pascual, J.; Bustamante, A.; Penalba, A.; Comas, I.; Rodriguez, M.; De Lera Alfonso, M.; Arenillas, J.F.; de Torres, R.; Pérez-Sánchez, S.; Cabezas, J.A.; Moniche, F.; González-Alujas, T.; Molina, C.A.; Montaner, J. 2021: B-type natriuretic peptide over N-terminal pro-brain natriuretic peptide to predict incident atrial fibrillation after cryptogenic stroke European Journal of Neurology 28(2): 540-547
Prontera, C.; Emdin, M.; Zucchelli, G.C.; Ripoli, A.; Passino, C.; Clerico, A. 2004: Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide Clinical Chemistry and Laboratory Medicine 42(1): 37-44
Nishikimi, T.; Matsuoka, H. 2004: Are plasma levels of atrial natriuretic peptide, N-terminal ProANP, and brain natriuretic peptide affected by the presence of coronary artery disease? Circulation 109(25): E331; Author Reply E331
Dai, M.; Wen, Q.-x.; He, J.-r. 2006: Effects of xinshuai mistura on plasma angiotensin II, atrial natriuretic peptide and N terminal pro-brain natriuretic peptide in patients with heart failure Zhongguo Zhong Xi Yi Jie he Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi 26(10): 888-891
Honkonen, E.L.; Kaukinen, L.; Pehkonen, E.J.; Kaukinen, S. 1997: Atrial natriuretic peptide and N-terminal atrial natriuretic peptide in plasma reflect right ventricular volumes following coronary artery surgery Acta Anaesthesiologica Scandinavica 41(6): 685-693